Results from the Atherosclerosis Risk in Communities study suggest that low serum magnesium is associated with incident kidney disease
about
Proton pump inhibitors for the treatment of patients with erosive esophagitis and gastroesophageal reflux disease: current evidence and safety of dexlansoprazoleMagnesium and type 2 diabetesGenetic loci for serum magnesium among African-Americans and gene-environment interaction at MUC1 and TRPM6 in European-Americans: the Atherosclerosis Risk in Communities (ARIC) study.Hypomagnesemia Is Associated with Increased Mortality among Peritoneal Dialysis Patients.Hypomagnesemia and Mortality in Incident Hemodialysis PatientsDietary Acid Load and Incident Chronic Kidney Disease: Results from the ARIC StudyProton Pump Inhibitor Use and the Risk of Chronic Kidney Disease.Sevelamer carbonate reduces the risk of hypomagnesemia in hemodialysis-requiring end-stage renal disease patientsEffects of Magnesium on the Phosphate Toxicity in Chronic Kidney Disease: Time for Intervention Studies.The impact of hypomagnesemia on erectile dysfunction in elderly, non-diabetic, stage 3 and 4 chronic kidney disease patients: a prospective cross-sectional study.Effects of Canagliflozin on Serum Magnesium in Patients With Type 2 Diabetes Mellitus: A Post Hoc Analysis of Randomized Controlled Trials.Magnesium and cardiovascular complications of chronic kidney disease.The effect of magnesium supplementation on vascular calcification in chronic kidney disease-a randomised clinical trial (MAGiCAL-CKD): essential study design and rationale.Clinical features of CKD-MBD in Japan: cohort studies and registry.Serum magnesium and risk of new onset heart failure in men: the Kuopio Ischemic Heart Disease Study.Perspective: The Case for an Evidence-Based Reference Interval for Serum Magnesium: The Time Has Come.Inherited and acquired disorders of magnesium homeostasis.Proton Pump Inhibitors: More Indigestion than Relief?DASH (Dietary Approaches to Stop Hypertension) Diet and Risk of Subsequent Kidney Disease.Proton Pump Inhibitors and Kidney Disease - GI Upset for the Nephrologist?Dietary Habits and Risk of Kidney Function Decline in an Urban Population.Dietary Magnesium and Kidney Function Decline: The Healthy Aging in Neighborhoods of Diversity across the Life Span Study.Proton Pump Inhibitors and Risk of Incident CKD and Progression to ESRD.Enhanced selectivity for Mg2+ with a phosphinate-based chelate: APDAP versus APTRA.Association of serum magnesium with all-cause mortality in patients with and without chronic kidney disease in the Dallas Heart Study.Magnesium Replacement to Protect Cardiovascular and Kidney Damage? Lack of Prospective Clinical Trials.Severely low serum magnesium is associated with increased risks of positive anti-thyroglobulin antibody and hypothyroidism: A cross-sectional study.
P2860
Q26741015-FF467931-940F-4F51-901F-02C57C2766FDQ26795771-600457D9-529E-4703-8FE1-7A8F6F3DAC7AQ35658770-A8EA6493-1AEA-4EFA-A04D-B35681ACEDD3Q35972910-B9498D91-B356-43C7-9757-1F49B6A0263DQ36315868-67050CCB-0B51-424E-A483-17A1B272DB2FQ36522360-F29AE822-91DB-4500-89B7-D13332AC4A4AQ36635329-2823BCED-42C1-4623-B409-39C7CE550CA9Q36951232-AD72B021-743C-43F5-B4D8-93214C0F843AQ37673143-A2308FBC-C1CD-4AD4-BAD0-722F88749692Q37684649-A5265ABA-88B0-4C81-B5B8-92CA195DE30BQ37737458-C40D17BD-8853-48DF-9BA5-91C2F4614BDDQ38473932-66F3FAD1-A257-43EA-A7B6-91ECD7AB4E29Q38711321-969B5487-59F7-424E-95A5-C14C2C565F8BQ38784139-83511A97-1438-4F1C-92CC-A383CBC20A27Q38862988-5C980350-30B7-4BB5-8843-F1F5041C99AEQ38989905-E4DC8592-C2E1-40F2-810E-BFB07EDACB1EQ39025913-DF9203DA-CD85-4077-AE3E-487C270D8537Q39152043-BF6CD414-0A43-4347-9D03-5E49F597BC4FQ39494977-A0A2EF86-128F-4919-9B62-F9392F6A7FA5Q40068373-560D5BA9-ED38-48DB-9C39-2356EA4FA9EEQ40414942-AC7FCAA6-8A47-4389-991B-FAEECCA17787Q40414969-D5D61F97-25E9-4D15-B9C5-F306D11519D1Q40799000-E6748BAD-0C8C-47E5-8D13-72FEDA76B497Q50031694-4958691A-5302-47E4-8828-E2C014CF6714Q50097171-3A3F7B9A-69E3-4E79-971F-92F647D510D0Q54963847-6B76A5B4-9879-4ABA-B7BB-CA484354D635Q55517638-ECAB9A40-E447-4CAF-A3B6-CB334BDCAAA5
P2860
Results from the Atherosclerosis Risk in Communities study suggest that low serum magnesium is associated with incident kidney disease
description
2014 nî lūn-bûn
@nan
2014 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Results from the Atheroscleros ...... d with incident kidney disease
@ast
Results from the Atheroscleros ...... d with incident kidney disease
@en
type
label
Results from the Atheroscleros ...... d with incident kidney disease
@ast
Results from the Atheroscleros ...... d with incident kidney disease
@en
prefLabel
Results from the Atheroscleros ...... d with incident kidney disease
@ast
Results from the Atheroscleros ...... d with incident kidney disease
@en
P2093
P2860
P50
P356
P1433
P1476
Results from the Atheroscleros ...... d with incident kidney disease
@en
P2093
Adrienne Tin
Brad C Astor
David Couper
Morgan E Grams
Nisa M Maruthur
Wen Hong Linda Kao
P2860
P2888
P304
P356
10.1038/KI.2014.331
P407
P577
2014-10-01T00:00:00Z